Stockscreener 앱 받기
11.13
0.91%
0.10
시간 외 거래:
11.13
전일 마감가:
$11.03
열려 있는:
$11.19
하루 거래량:
55,396
Relative Volume:
1.57
시가총액:
$39.63M
수익:
-
순이익/손실:
$-55.84M
주가수익비율:
-0.6326
EPS:
-17.5951
순현금흐름:
$-49.61M
1주 성능:
+4.21%
1개월 성능:
-10.17%
6개월 성능:
+81.65%
1년 성능:
+2,785%
1일 변동 폭
$10.46
$11.73
1주일 범위
$10.31
$11.73
52주 변동 폭
$0.224
$15.74
Nextcure Inc Stock (NXTC) Company Profile
명칭
Nextcure Inc
전화
240-399-4900
주소
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
11.13 | 39.27M | 0 | -55.84M | -49.61M | -17.60 |
VRTX
Vertex Pharmaceuticals Inc
|
431.86 | 110.47B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
760.27 | 80.67B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
765.43 | 46.53B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.52 | 43.81B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.03 | 35.36B | 606.42M | -1.28B | -997.58M | -6.403 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2022-11-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-03-05 | 업그레이드 | Truist | Hold → Buy |
| 2021-01-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-07-16 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-07-13 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-13 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-06-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-05-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-03-24 | 개시 | The Benchmark Company | Buy |
| 2020-03-02 | 개시 | ROTH Capital | Buy |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-12-05 | 개시 | Needham | Buy |
| 2019-11-26 | 개시 | BTIG Research | Buy |
| 2019-07-09 | 개시 | BofA/Merrill | Buy |
| 2019-06-03 | 개시 | Morgan Stanley | Overweight |
| 2019-06-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Nextcure Inc 주식(NXTC)의 최신 뉴스
NextCure Gets FDA Fast Track for SIM0505 in Ovarian Cancer - National Today
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer - Bitget
Resistance Check: Is NextCure Inc exposed to currency risksMarket Performance Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Trend Report: Will Investcorp Credit Management BDC Inc Preferred Security outperform tech stocksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
NXTC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Buyout Rumor: Will American Tower Corporation stock go up in YEAR2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
NXTC Should I Buy - Intellectia AI
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 - The Manila Times
Phase 1 cancer drug abstract lands ASCO 2026 slot in Chicago - Stock Titan
Price Action: Is Oriental Culture Holding LTD stock a top performer YTD2026 Selloffs & Daily Entry Point Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
BLRX PE Ratio & Valuation, Is BLRX Overvalued - Intellectia AI
Bond Watch: Is NextCure Inc stock showing strong momentumQuarterly Portfolio Summary & Verified Entry Point Signals - baoquankhu1.vn
NextCure, Inc.Common Stock (NQ: NXTC - FinancialContent
Retail Trends: Why is GGNPRB stock going downLong Setup & Smart Investment Allocation Insights - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NIVFPrice, Charts & Blockchain Insights - Intellectia AI
ITVI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MMMM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Buy Signal: Is NextCure Inc a defensive stockQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Action: Is CF Bankshares Incs growth already priced in2026 Chart Watch & Proven Capital Preservation Methods - baoquankhu1.vn
Published on: 2026-03-22 18:56:49 - baoquankhu1.vn
BOLD Technical Analysis & Price Forecast - Intellectia AI
LOW Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HTH Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
BKT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BSX Technical Analysis & Price Forecast - Intellectia AI
CULP Should I Buy - Intellectia AI
Travel Stocks: Is NextCure Inc stock good for income investorsTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
NextCure Inc Stock (ISIN: US65343E1082) Faces Analyst Downgrade Amid Biotech Sector Headwinds - AD HOC NEWS
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment - MSN
NextCure Provides Business Update and Reports Full Year 2025 Financial Results - The Manila Times
NextCure Inc reports results for the quarter ended September 30Earnings Summary - TradingView
NextCure 10-K: $0 Revenue, $(19.65) EPS reported - TradingView
NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NXTC SEC FilingsNextcure 10-K, 10-Q, 8-K Forms - Stock Titan
NextCure, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NextCure Inc expected to post a loss of $2.42 a shareEarnings Preview - TradingView
Hedge Fund Bets: Is NextCure Inc stock good for income investorsJuly 2025 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
NXTC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NextCure (NXTC) Projected to Post Quarterly Earnings on Thursday - Defense World
Published on: 2026-02-26 09:55:29 - baoquankhu1.vn
NextCure (NASDAQ:NXTC) Stock Price Down 3.7% – What’s Next? - Defense World
Can NextCure Inc. stock double in next 5 yearsWeekly Investment Report & Technical Entry and Exit Tips - mfd.ru
Squadron funds disclose 9.99% holding in NextCure (NXTC) common stock - Stock Titan
Will The Allstate Corporation stock benefit from green energy trendsIPO Watch & Weekly Return Optimization Alerts - mfd.ru
NXTC Technical Analysis & Stock Price Forecast - Intellectia AI
Is FSLR stock a top pick in earnings seasonMarket Trend Summary & Precise Swing Trade Alerts - mfd.ru
Street Watch: Is NextCure Inc stock showing strong momentumGap Down & Community Verified Trade Signals - baoquankhu1.vn
Cancer index surges 72% as Terns, Olema lead gains - BioWorld MedTech
Nextcure Inc (NXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
2.75%
자본화:
|
볼륨(24시간):